Tag: Tau protein

Browse exclusive Tags!

Researchers Develop mRNA Technology to Target Harmful Protein in Alzheimer’s Patients, Australia

Researchers at The Florey have developed mRNA technology to target harmful proteins in Alzheimer's patients, offering new hope for more effective treatments.

Lilly’s Alzheimer’s drug shows 60% decrease in mild impairment during clinical trial

Lilly's Donanemab Slows Alzheimer's by 60% in Early Stages

Experimental Eli Lilly Drug Slows Alzheimer’s Progression by 60% Among Mildly Impaired Patients in Clinical Trial

Eli Lilly's donanemab drug shows promising results in slowing Alzheimer's progression by 60% for early-stage patients, but with notable side effects. Read more.

Popular

Experimental Eli Lilly Drug Slows Alzheimer’s Progression by 60% Among Mildly Impaired Patients in Clinical Trial

Eli Lilly's donanemab drug shows promising results in slowing Alzheimer's progression by 60% for early-stage patients, but with notable side effects. Read more.

Researchers Develop mRNA Technology to Target Harmful Protein in Alzheimer’s Patients, Australia

Researchers at The Florey have developed mRNA technology to target harmful proteins in Alzheimer's patients, offering new hope for more effective treatments.

Subscribe

spot_imgspot_img